학술논문

Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat.
Document Type
Article
Source
JAMA: Journal of the American Medical Association. 1/20/99, Vol. 281 Issue 3, p235. 8p. 1 Diagram, 4 Charts, 4 Graphs.
Subject
*WEIGHT loss
*FAT
*LIPASE inhibitors
*OBESITY treatment
*ABSORPTION
*EQUIPMENT & supplies
Language
ISSN
0098-7484
Abstract
Presents a study of orlistat, a gastrointestinal lipase inhibitor that reduces dietary fat absorption. Efforts to test the hypothesis that orlistat combined with dietary intervention is more effective than placebo plus diet for weight loss and maintenance over a two year period; Setting and participants; Intervention; Main outcome measures; Results; Conclusions.